Global Health

Improving care globally

We provide people with access to adequate high-quality healthcare, for example:

  • We improved access to better therapies in diabetes, cancer, hypertension, and fertility in underserved regions through the company's Capacity Advancement Program
  • We strengthened the group's Global Health Institute to accelerate R&D, incorporate access provisions and build capacity
  • We conduct awareness campaigns e.g. for diabetes, thyroid disorders and cancer
Best Practice

Transparency on patents to insure public health meeds: Pat-INFORMED initiative recognized as a best practice in the 2018 Access to Medicine Index


Colorectal Cancer Awareness Month campaign #gutstrength reached 162,000 people

Preventing and treating infectious diseases

  • We aim to eliminate the worm disease schistosomiasis
    • Since 2007, we have donated over 1 billion praziquantel tablets to WHO for distribution across 46 nations in Africa
    • We support the NALA Foundation with a Schistosomiasis Health Education Project targeting 850,000 people in Ethiopia
    • We are developing a pediatric formulation of praziquantel for children under the age of six (Phase III study will be implemented in 2019)
  • We help delivering integrated and sustainable health solutions against malaria (treatments, diagnostics, prevention methods)
  • New compound is being developed as a single-dose combination to treat and potentially prevent malaria in children (Phase I study underway since 2017)

Read more


You have accessed, but for users from your part of the world, we originally designed the following web presence

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement